Chris Poulios, Pathologist-Educational Project Manager at EUROPEAN SOCIETY OF PATHOLOGY, shared a post on LinkedIn:
“Hot pathology takes from ASCO 2026!
What better way to enjoy a congress than been with like-minded colleagues!
Meet the 2 ESPAlumni who attended the ASCO26 in Chicago, just a few days ago!
João Lobo and Alessandro Gambella were European Society of Pathology ambassadors, both past awardees of the ESP Academy!
Under the supervision of Catarina Eloy they will be preparing the ‘Highlights from ASCO 2026‘ session at the ESP Congress!
We will have much to discuss, including but not limited to:
- HUGE news about RAS inhibitors for pancreatic cancer. A true game-changer!
- Parp inhibitors for prostate cancer
- Promising news for triple-negative breast cancer
- New options for squamous cell carcinomas of the lung and H&N
- Opportunities for HE to shine with the help of AI
- And of course, commentaries from pathology and oncology KOLs who will be sharing their own insights!
If you are a healthcare professional working in pathology and cancer, you are more than welcome to join us in Stockholm and the ‘Highlights from ASCO 2026’ session!
Secure your slot at the best pathology congress: 38th European Congress of Pathology.”
Other articles featuring Chris Poulios on OncoDaily.